

A week ago, I discussed the role of bad decision making in pharma’s woes. I agreed with a senior management consultant that human factors impact both forecasting and drug development decisions, but I wasn’t sure that (at least in early stage projects) forecasting or drug development decisions would be significantly improved by “objective” or “optimal” processes, however you define that.
http://twt.lu/XKxG2d